https://www.selleckchem.com/pr....oducts/adavivint.htm
progression compared with patients with HbA1c level below 6.5% (HR=2.838, 95%CI 1.505-5.349, P=0.001). Compared with non-diabetic patients, diabetic patients with HbA1c below 6.5% also had lower risk of lesion progression (HR=0.469, 95%CI 0.252-0.872, P=0.012). ST-segment elevated myocardial infarction was an independent predictor for revascularization of non-target lesions in diabetic patients. Conclusion Type 2 diabetes mellitus is not an independent predictor for progression and revascularization of coronary non-target lesions in p
Like
Comment
Share
